Abstract
Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.
| Original language | English |
|---|---|
| Pages (from-to) | 8915–8918 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 61 |
| Issue number | 49 |
| Early online date | 21 May 2025 |
| DOIs | |
| Publication status | Published - 21 Jun 2025 |
Fingerprint
Dive into the research topics of 'Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver